IP Verse

Methods Of Treating Hepatic Encephalopathy - EP2350096B1

PatentPatent Analysis

EP2350096

SALIX PHARMACEUTICALS
Application Number
EP09818544A
Filing Date
Oct 2, 2009
Status
Granted And Under Opposition
Nov 8, 2019
Grant Date
Dec 11, 2019
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3628319B1
EP2252148B1

Bibliography

The patent EP2350096B1 was granted to Salix Pharmaceuticals on Dec 11, 2019 following the initial filing on Oct 2, 2009 under the application number EP09818544A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (8)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ALFRED E TIEFENBACHERSep 11, 2020ADMISSIBLE
HOLLATZSep 11, 2020ADMISSIBLE
STADA ARZNEIMITTELSep 11, 2020ADMISSIBLE
ACCORD HEALTHCARESep 9, 2020ADMISSIBLE
TEVA PHARMACEUTICALSSep 9, 2020ADMISSIBLE
AERASep 7, 2020ADMISSIBLE
KRAUS & LEDERER PARTGMBBAug 31, 2020ADMISSIBLE
CMS CAMERON MCKENNA NABARRO OLSWANGAug 6, 2020ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents